Elevated HbA1C linked to cardiovascular events in elderly diabetics
Article written by Bruce Sylvester Glycated hemoglobin A1c (HbA1c) greater than 7% correlates with an increased risk of cardiovascular events in elderly patients..
Article written by Bruce Sylvester Glycated hemoglobin A1c (HbA1c) greater than 7% correlates with an increased risk of cardiovascular events in elderly patients..
Article written by Bruce Sylvester Elderly patients without atherosclerotic cardiovascular disease (ASCVD) who initiated statin therapy have achieved a 25% reduction in the risk of early death..
Moderna, Inc. announced the publication of an interim analysis of the open-label Phase 1 study of mRNA-1273, its vaccine candidate against COVID-19, in The New England Journal of… read more.
Idorsia Ltd announced positive top-line results of the second pivotal Phase III study investigating 10 and 25 mg doses of its dual orexin receptor antagonist, daridorexant , in… read more.
Written by Bruce Sylvester Researchers report that there is no link between statin use and cognitive decline. The findings were published on Nov. 18, 2019 in the Journal… read more.
Oligorecurrent and oligoprogressive NSCLC represent a treatment challenge. A case example of synchronous oligometastatic disease provided the framework for expert discussion…….. Written by Christine Clark.
A recent study completed at the University of Helsinki investigated the amount and quality of bacteria resistant to antibiotics in breast milk and the gut of mother-infant pairs,… read more.
Most patients die within 5 years and spend two-thirds of remaining life as an inpatient.
Article written by Tom Collins. Interview by Esther Drain. Meletios Dimopoulos, MD, professor and chairman of clinical therapeutics at the University of Athens and a long-time expert in… read more.
Prof Peter Johnson (Southampton, UK) discusses where there is consensus and controversy in the management of HL in 2019, as well as talking about the key takeaways from… read more.
Professor Graham Jackson (Newcastle, UK) gives an overview of his presentation on real world management of myeloma patients in the UK, with comments from Professor Sagar Lonial (Atlanta,… read more.
Advertisment